- Home
- SNN vs RVTY Comparison
SNN vs RVTY Comparison
Compare SNN & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNN
- RVTY
- Stock Information
- Founded
- SNN 1856
- RVTY 1937
- Country
- SNN United Kingdom
- RVTY United States
- Employees
- SNN N/A
- RVTY N/A
- Industry
- SNN Industrial Specialties
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- SNN Health Care
- RVTY Industrials
- Exchange
- SNN Nasdaq
- RVTY Nasdaq
- Market Cap
- SNN 13.2B
- RVTY 11.4B
- IPO Year
- SNN 1999
- RVTY N/A
- Fundamental
- Price
- SNN $37.42
- RVTY $90.13
- Analyst Decision
- SNN Hold
- RVTY Buy
- Analyst Count
- SNN 3
- RVTY 13
- Target Price
- SNN $31.50
- RVTY $120.08
- AVG Volume (30 Days)
- SNN 900.3K
- RVTY 1.1M
- Earning Date
- SNN 10-30-2025
- RVTY 07-28-2025
- Dividend Yield
- SNN 1.96%
- RVTY 0.31%
- EPS Growth
- SNN 59.91
- RVTY 72.56
- EPS
- SNN 0.56
- RVTY 2.37
- Revenue
- SNN $5,944,000,000.00
- RVTY $2,798,467,000.00
- Revenue This Year
- SNN $7.75
- RVTY $5.55
- Revenue Next Year
- SNN $5.37
- RVTY $4.40
- P/E Ratio
- SNN $33.13
- RVTY $38.07
- Revenue Growth
- SNN 5.35
- RVTY 3.33
- 52 Week Low
- SNN $23.69
- RVTY $85.12
- 52 Week High
- SNN $37.65
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- SNN 70.69
- RVTY 47.65
- Support Level
- SNN $37.02
- RVTY $87.64
- Resistance Level
- SNN $37.65
- RVTY $94.72
- Average True Range (ATR)
- SNN 0.34
- RVTY 2.35
- MACD
- SNN -0.12
- RVTY 0.23
- Stochastic Oscillator
- SNN 80.12
- RVTY 48.73
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.